Nuwellis Inc

Nuwellis Inc

NUWE · NASDAQ · Healthcare / Medical Devices

4.90USD-0.13 (-2.58%)

Price History

Full chart

Market Stats

Previous Close5.03
Open5.05
Day Range4.79 – 5.27
52-Week Range0.71 – 172.90
Volume21.94K
Market Cap2.46M
P/E (TTM)0.00
Forward P/E0.00
EPS2,548.34
Dividend Yield0.00%
Beta0.23
50-Day Avg1.43
200-Day Avg36.09

About

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Michael Kendrick McCormick
  • Employees38
  • Headquarters12988 Valley View Road, Eden Prairie, MN, United States, 55344, USA
  • Websitehttps://www.nuwellis.com

Leadership

  • Mr. Michael Kendrick McCormickPresident, CEO & Director · b. 1962
  • Mr. Neil P. Ayotte Esq.Senior VP, General Counsel, Secretary & Chief Compliance Officer · b. 1963
  • Ms. Carisa SchultzCFO, Principal Financial Officer & Principal Accounting Officer · b. 1978
  • Ms. Kim AndersonVice President, Research & Development, Quality and Operations
  • Mr. David LernerChief Technology Officer
  • Leah McMullenDirector of Communications
  • Mr. Paul WottaCorporate Controller · b. 1958

Financials

Income Statement

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.43K381.76K1.25M2.73M422.04K108.30K400.02K400.02K--59.00K295.00K59.00K1.29M3.55M5.00M5.51M7.44M7.92M8.54M8.86M8.74M8.27M
Growth (%)-+1529.30%+228.25%+117.99%-84.55%-74.34%+269.36%0.00%---+400.00%-80.00%+2084.75%+175.64%+40.67%+10.26%+35.02%+6.45%+7.85%+3.76%-1.40%-5.38%
Cost of Revenue------------325.00K713.00K2.76M3.67M2.66M3.38M3.43M3.79M3.88M2.91M3.15M
Gross Profit23.43K381.76K1.25M2.73M422.04K108.30K400.02K400.02K--59.00K295.00K-266.00K576.00K790.00K1.33M2.85M4.06M4.49M4.75M4.98M5.83M5.12M
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%--100.00%100.00%-450.85%44.69%22.23%26.57%51.73%54.52%56.70%55.66%56.22%66.66%61.96%
Operating Expense1.22M4.17M6.69M12.52M9.74M6.86M6.62M6.62M--22.93M26.08M25.69M16.24M15.60M18.36M20.96M21.09M24.02M21.93M22.61M16.81M16.23M
Operating Income-1.20M-3.79M-5.44M-9.79M-9.32M-6.75M-6.22M-6.22M-16.56M-14.87M-22.87M-25.79M-25.96M-15.66M-14.81M-17.04M-18.11M-17.03M-19.53M-17.17M-17.63M-10.99M-11.11M
Operating Margin-5120.43%-993.53%-433.77%-358.29%-2207.60%-6236.49%-1554.76%-1554.76%---38764.41%-8741.36%-43996.61%-1215.05%-416.89%-340.86%-328.54%-228.84%-246.51%-200.99%-198.89%-125.72%-134.29%
EBITDA-4.18M-5.40M-9.73M-8.64M-6.46M-6.39M-11.81M-11.81M-16.26M-14.70M-22.69M-25.51M-25.64M-14.64M-10.09M-16.80M-17.87M-16.65M-19.06M-4.90M-16.36M-10.53M-6.55M
EBITDA Margin-17855.38%-1414.85%-776.70%-316.32%-1531.59%-5898.77%-2952.11%-2952.11%---38450.85%-8647.46%-43455.93%-1136.15%-284.04%-336.21%-324.21%-223.79%-240.59%-57.32%-184.52%-120.46%-79.15%
Net Income-1.01M-3.82M-5.22M-9.79M-9.32M-6.52M-5.55M-5.55M-16.20M-14.06M-21.76M-25.59M-26.58M-15.79M-13.38M-17.03M-18.11M-15.84M-19.55M-14.53M-20.21M-11.16M-17.52M
Net Income Margin-4324.88%-999.77%-416.61%-358.29%-2207.60%-6020.39%-1387.90%-1387.90%---36877.97%-8673.56%-45055.93%-1225.14%-376.64%-340.78%-328.69%-212.82%-246.86%-170.02%-227.99%-127.75%-211.86%
R&D461.51K2.44M4.40M8.73M5.58M2.52M2.95M2.95M11.20M8.00M13.50M16.87M17.67M8.11M1.48M3.05M4.67M3.67M4.98M4.34M5.42M3.21M2.71M
R&D as % of Total Revenue1969.64%640.16%351.09%319.67%1322.72%2326.02%736.90%736.90%--22888.14%5720.00%29952.54%629.09%41.68%61.08%84.78%49.29%62.85%50.83%61.17%36.72%32.79%
Interest Expense3.99K23.83K000000251.00K33.00K100.00K49.00K743.00K504.00K2.54M10.00K02.40M43.00K9.25M3.48M5.61M10.55M
Interest Expense % of Total Revenue17.04%6.24%0.00%0.00%0.00%0.00%0.00%0.00%--169.49%16.61%1259.32%39.10%71.57%0.20%0.00%32.29%0.54%108.24%39.29%64.15%127.61%

Balance Sheet

Currency: USD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.28M1.41M7.64M4.75M7.11M9.74M1.98M4.47M4.47M7.43M15.04M55.23M32.37M24.57M7.47M18.45M8.78M5.60M20.01M30.42M24.67M9.77M9.86M6.12M
Total Liabilities161.33K1.27M337.38K366.54K218.63K233.02K345.55K457.53K457.53K2.83M2.09M3.50M3.16M12.40M5.71M2.22M2.84M3.61M3.69M4.47M12.32M6.56M3.33M3.49M
Total Equity1.12M139.47K7.30M4.38M6.89M9.51M1.64M4.02M4.02M4.60M12.95M51.73M29.21M12.17M1.76M16.24M5.94M1.99M16.32M25.95M12.36M3.21M6.53M2.62M
Cash1.17M928.13K6.01M3.36M6.55M9.35M1.63M3.35M3.35M6.56M14.22M54.14M31.29M23.11M1.32M15.60M5.48M1.28M14.44M8.74M17.74M3.80M5.09M1.08M
Total Debt-------------7.80M---447.00K339.00K1.18M984.00K760.00K545.00K328.00K
Net Debt-1.17M-928.13K-6.01M-3.36M-6.55M-9.35M-1.63M-3.35M-3.35M-6.56M-14.22M-54.14M-31.29M-15.31M-1.32M-15.60M-5.48M-832.00K-14.10M-7.57M-16.75M-3.04M-4.55M-757.00K

Cash Flow

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.24M-4.84M-4.70M-8.48M-8.76M-6.25M-6.18M-6.18M-13.09M-13.08M-17.36M-22.64M-22.99M-16.29M-11.92M-14.56M-16.37M-16.57M-17.84M-15.15M-17.94M-9.59M-10.81M
Investing Cash Flow-9.55K-77.97K-90.09K-147.79K-8.50K-6.91K--4.34K-451.00K-158.00K-293.00K-351.00K-199.00K-4.12M-259.00K-198.00K-490.00K-267.00K-15.72M14.73M330.00K-60.00K-90.00K
Financing Cash Flow964.88K9.92M2.28M11.40M10.73M07.86M7.86M7.63M20.84M57.57M89.00K15.05M-1.36M26.45M4.65M12.66M30.02M27.87M9.42M3.68M10.96M6.94M
Capital Expenditure9.55K77.97K90.09K147.79K8.50K6.91K4.34K4.34K451.00K158.00K293.00K351.00K199.00K117.00K259.00K198.00K490.00K298.00K219.00K122.00K248.00K60.00K90.00K
Free Cash Flow-1.25M-4.92M-4.79M-8.63M-8.76M-6.26M-6.18M-6.18M-13.54M-13.24M-17.66M-23.00M-23.19M-16.41M-12.18M-14.76M-16.86M-16.87M-18.06M-15.27M-18.18M-9.65M-10.90M
Dividends Paid--------------------2.30M541.00K-
FCF to OCF100.77%101.61%101.92%101.74%100.10%100.11%100.07%100.07%103.45%101.21%101.69%101.55%100.87%100.72%102.17%101.36%102.99%101.80%101.23%100.81%101.38%100.63%100.83%
Dividend Paid to FCF---------------------12.63%-5.61%-

Earnings

Report DateMay 10, 2012Jul 30, 2012Nov 8, 2012Mar 11, 2013May 14, 2013Aug 7, 2013Nov 11, 2013Mar 11, 2014May 13, 2014Aug 12, 2014Oct 30, 2014Mar 17, 2015May 5, 2015Aug 4, 2015Nov 3, 2015Mar 3, 2016May 3, 2016Aug 9, 2016Nov 8, 2016Mar 2, 2017May 9, 2017Aug 8, 2017Oct 31, 2017Mar 20, 2018May 8, 2018Aug 7, 2018Nov 6, 2018Feb 20, 2019May 7, 2019Aug 6, 2019Nov 5, 2019Mar 3, 2020May 12, 2020Aug 4, 2020Nov 10, 2020Mar 2, 2021May 11, 2021Aug 10, 2021Nov 9, 2021Mar 1, 2022May 10, 2022Aug 9, 2022Nov 8, 2022Feb 28, 2023May 9, 2023Aug 8, 2023Nov 7, 2023Mar 5, 2024May 7, 2024Aug 13, 2024Nov 11, 2024Mar 3, 2025May 13, 2025Aug 14, 2025Nov 12, 2025Mar 10, 2026May 12, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate-1000000.00-1000000.00-1000000.00-1000000.00-128100.00-1000000.00-1000000.00-1000000.00-104895.00-1000000.00-1000000.00-101745.00-1000000.00-1000000.00-1000000.00-93660.00-1000000.00-1000000.00-1000000.00--1000000.00-1000000.00-1000000.00-52920.00-1000000.00-1000000.00-1000000.00-22680.00-1000000.00-1000000.00-1000000.00-2400.00-1000000.00-1000000.00-1000000.00-191.00-1000000.00-1000000.00-1000000.00-47.67-1000000.00-1000000.00-1000000.00-17.09-430123.29-207001.12-160181.48-71515.71-1.06-12120.18-1881.60-0.43-661.50-661.50-602.70-1.56-35.00-23.80-13.65
EPS Actual-1000000.00-1000000.00-1000000.00-1000000.00-118440.00-1000000.00-1000000.00-1000000.00-95760.00-1000000.00-1000000.00-100800.00-1000000.00-1000000.00-1000000.00-90720.00-1000000.00-1000000.00-1000000.00-38976.00-1000000.00-1000000.00-1000000.00-187320.00-1000000.00-1000000.00-1000000.00-25110.00-1000000.00-1000000.00-1000000.00-3360.00-1000000.00-1000000.00-1000000.00-157.00-1000000.00-1000000.00-1000000.00-41.00-1000000.00-1000000.00-1000000.00-5.00-261820.06-187793.06-93124.78-115248.35-0.60-27709.562557.81-0.44-1014.30-2134.6519.60-1.50-73.15-26.64-
Surprise0.00%0.00%0.00%0.00%7.54%0.00%0.00%0.00%8.71%0.00%0.00%0.93%0.00%0.00%0.00%3.14%0.00%0.00%0.00%-0.00%0.00%0.00%-253.97%0.00%0.00%0.00%-10.71%0.00%0.00%0.00%-40.00%0.00%0.00%0.00%17.80%0.00%0.00%0.00%13.99%0.00%0.00%0.00%70.74%39.13%9.28%41.86%-61.15%43.40%-128.62%235.94%-2.33%-53.33%-222.70%103.25%3.85%-109.00%-11.93%-
TimingAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.46M
Enterprise Value-1.04M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.27
Price / Book0.18
EPS2,548.34
Book Value-3.58
Revenue (TTM)9.01M
Gross Profit (TTM)6.28M
EBITDA-12.72M
Profit Margin-125.63%
Operating Margin-160.95%
Return on Equity-609.44%
Return on Assets-87.83%
Shares Outstanding3.18M
Shares Float3.45M
Beta0.23
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 11.00
  • Buy
    1

Ownership Breakdown

Institutions
2.59%
Insiders
4.96%
Retail / Other
92.45%

Top Institutional Holders

  • Armistice Capital, LLC
    236.20K1.85%
  • Geode Capital Management, LLC
    44.18K0.35%
  • Tower Research Capital LLC
    5.19K0.04%
  • Citigroup Inc
    5.13K0.04%
  • SBI Securities Co Ltd
    630.00%
  • UBS Group AG
    460.00%
  • Caitong International Asset Management Co., Limited.
    40.00%
  • Ankerstar Wealth, LLC
    10.00%
  • DRW Securities, LLC
    00.00%
  • Sabby Management LLC
    00.00%
  • XTX Topco Ltd
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    6090.02%
  • Fidelity Series Total Market Index
    420.00%

Stock Splits

  • Oct 27, 20261:9
  • Jun 26, 20261:35
  • Jul 7, 20251:42
  • Jun 28, 20241:35
  • Dec 12, 20221:100
  • Oct 19, 20201:30
  • Jan 3, 20191:14
  • Oct 13, 20171:20
  • Jan 13, 20171:30